APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Injection General Anesthesia Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Intravenous Injection General Anesthesia Drugs Industry Growth and Trends Forecast to 2032

22 December 2025114 pages

Choose your research edition.

Industry ResearchIntravenous Injection General Anesthesia Drugs Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Injection General Anesthesia Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Intravenous Injection General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Injection General Anesthesia Drugs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Injection General Anesthesia Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Intravenous Injection General Anesthesia Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Intravenous Injection General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Intravenous Injection General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Injection General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intravenous Injection General Anesthesia Drugs include Aspen Pharma, Hikma Pharmaceuticals, Maruishi, Maruishi, Piramal, AstraZeneca, AbbVie, Baxter Healthcare and B.Braun, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Intravenous Injection General Anesthesia Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intravenous Injection General Anesthesia Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intravenous Injection General Anesthesia Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intravenous Injection General Anesthesia Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intravenous Injection General Anesthesia Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intravenous Injection General Anesthesia Drugs Market by Company

Aspen Pharma

Hikma Pharmaceuticals

Maruishi

Maruishi

Piramal

AstraZeneca

AbbVie

Baxter Healthcare

B.Braun

Fresenius-Kabi

China National Medicines Guorui Pharmaceutical Co.,Ltd.

Hengrui

Nhwa

Lunan Pharmaceutical Group Corporation

Xi'an Libang

Yichang Humanwell

Intravenous Injection General Anesthesia Drugs Segment by Type

Propofol

Sevoflurane

Remifentanil

Etomidate

Isoflurane

Other

Intravenous Injection General Anesthesia Drugs Segment by Application

Hopitals

Clinics

Others

Intravenous Injection General Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Injection General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Injection General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Injection General Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous Injection General Anesthesia Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intravenous Injection General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Propofol Table 2. Major Company of Sevoflurane Table 3. Major Company of Remifentanil Table 4. Major Company of Etomidate Table 5. Major Company of Isoflurane Table 6. Major Company of Other Table 7. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 9. Global Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Type (2021-2026) Table 10. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 11. Global Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Type (2021-2026) Table 12. Global Intravenous Injection General Anesthesia Drugs Price by Type (2021-2026) & (US$/unit) Table 13. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2027-2032) & (k units) Table 14. Global Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Type (2027-2032) Table 15. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2027-2032) & (US$ Million) Table 16. Global Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Type (2027-2032) Table 17. Global Intravenous Injection General Anesthesia Drugs Price by Type (2027-2032) & (US$/unit) Table 18. North America Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 19. North America Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 21. Europe Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 25. Latin America Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Intravenous Injection General Anesthesia Drugs Industry Trends Table 29. Intravenous Injection General Anesthesia Drugs Industry Drivers Table 30. Intravenous Injection General Anesthesia Drugs Industry Opportunities and Challenges Table 31. Intravenous Injection General Anesthesia Drugs Industry Restraints Table 32. Global Intravenous Injection General Anesthesia Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Company (2021-2026) Table 34. Global Intravenous Injection General Anesthesia Drugs Sales by Company (2021-2026) & (k units) Table 35. Global Intravenous Injection General Anesthesia Drugs Sales Share by Company (2021-2026) Table 36. Global Intravenous Injection General Anesthesia Drugs Market Price by Company (2021-2026) & (US$/unit) Table 37. Global Intravenous Injection General Anesthesia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Intravenous Injection General Anesthesia Drugs Major Company Production Sites and Headquarters Table 39. Global Intravenous Injection General Anesthesia Drugs Company, Product Type & Application Table 40. Global Intravenous Injection General Anesthesia Drugs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Intravenous Injection General Anesthesia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Intravenous Injection General Anesthesia Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2021-2026) & (k units) Table 45. Global Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Region (2021-2026) Table 46. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2021-2026) & (US$ Million) Table 47. Global Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Region (2021-2026) Table 48. Global Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 49. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2027-2032) & (k units) Table 50. Global Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Region (2027-2032) Table 51. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2027-2032) & (US$ Million) Table 52. Global Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Region (2027-2032) Table 53. Global Intravenous Injection General Anesthesia Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 54. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 56. Global Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Application (2021-2026) Table 57. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 58. Global Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Application (2021-2026) Table 59. Global Intravenous Injection General Anesthesia Drugs Price by Application (2021-2026) & (US$/unit) Table 60. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2027-2032) & (k units) Table 61. Global Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Application (2027-2032) Table 62. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2027-2032) & (US$ Million) Table 63. Global Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Application (2027-2032) Table 64. Global Intravenous Injection General Anesthesia Drugs Price by Application (2027-2032) & (US$/unit) Table 65. North America Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 66. North America Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 68. Europe Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 72. Latin America Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Aspen Pharma Company Information Table 76. Aspen Pharma Business Overview Table 77. Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Portfolio Table 79. Aspen Pharma Recent Development Table 80. Hikma Pharmaceuticals Company Information Table 81. Hikma Pharmaceuticals Business Overview Table 82. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Portfolio Table 84. Hikma Pharmaceuticals Recent Development Table 85. Maruishi Company Information Table 86. Maruishi Business Overview Table 87. Maruishi Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 89. Maruishi Recent Development Table 90. Maruishi Company Information Table 91. Maruishi Business Overview Table 92. Maruishi Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 94. Maruishi Recent Development Table 95. Piramal Company Information Table 96. Piramal Business Overview Table 97. Piramal Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Piramal Intravenous Injection General Anesthesia Drugs Product Portfolio Table 99. Piramal Recent Development Table 100. AstraZeneca Company Information Table 101. AstraZeneca Business Overview Table 102. AstraZeneca Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. AstraZeneca Intravenous Injection General Anesthesia Drugs Product Portfolio Table 104. AstraZeneca Recent Development Table 105. AbbVie Company Information Table 106. AbbVie Business Overview Table 107. AbbVie Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. AbbVie Intravenous Injection General Anesthesia Drugs Product Portfolio Table 109. AbbVie Recent Development Table 110. Baxter Healthcare Company Information Table 111. Baxter Healthcare Business Overview Table 112. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Portfolio Table 114. Baxter Healthcare Recent Development Table 115. B.Braun Company Information Table 116. B.Braun Business Overview Table 117. B.Braun Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. B.Braun Intravenous Injection General Anesthesia Drugs Product Portfolio Table 119. B.Braun Recent Development Table 120. Fresenius-Kabi Company Information Table 121. Fresenius-Kabi Business Overview Table 122. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 124. Fresenius-Kabi Recent Development Table 125. China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information Table 126. China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview Table 127. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Portfolio Table 129. China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Development Table 130. Hengrui Company Information Table 131. Hengrui Business Overview Table 132. Hengrui Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Hengrui Intravenous Injection General Anesthesia Drugs Product Portfolio Table 134. Hengrui Recent Development Table 135. Nhwa Company Information Table 136. Nhwa Business Overview Table 137. Nhwa Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. Nhwa Intravenous Injection General Anesthesia Drugs Product Portfolio Table 139. Nhwa Recent Development Table 140. Lunan Pharmaceutical Group Corporation Company Information Table 141. Lunan Pharmaceutical Group Corporation Business Overview Table 142. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 143. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Portfolio Table 144. Lunan Pharmaceutical Group Corporation Recent Development Table 145. Xi'an Libang Company Information Table 146. Xi'an Libang Business Overview Table 147. Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 148. Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Portfolio Table 149. Xi'an Libang Recent Development Table 150. Yichang Humanwell Company Information Table 151. Yichang Humanwell Business Overview Table 152. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 153. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Portfolio Table 154. Yichang Humanwell Recent Development Table 155. North America Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 156. North America Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 157. North America Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 158. North America Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (k units) Table 159. North America Intravenous Injection General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 160. North America Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. North America Intravenous Injection General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 162. North America Intravenous Injection General Anesthesia Drugs Market Share by Country (2021-2026) Table 163. North America Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. North America Intravenous Injection General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 165. Europe Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 166. Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 167. Europe Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 168. Europe Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (k units) Table 169. Europe Intravenous Injection General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 170. Europe Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Europe Intravenous Injection General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 172. Europe Intravenous Injection General Anesthesia Drugs Market Share by Country (2021-2026) Table 173. Europe Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Europe Intravenous Injection General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 175. Asia-Pacific Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 176. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 177. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 178. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (k units) Table 179. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 180. Asia-Pacific Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. Asia-Pacific Intravenous Injection General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 182. Asia-Pacific Intravenous Injection General Anesthesia Drugs Market Share by Country (2021-2026) Table 183. Asia-Pacific Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. Asia-Pacific Intravenous Injection General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 185. Latin America Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 186. Latin America Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 187. Latin America Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 188. Latin America Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (k units) Table 189. Latin America Intravenous Injection General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 190. Latin America Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 191. Latin America Intravenous Injection General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 192. Latin America Intravenous Injection General Anesthesia Drugs Market Share by Country (2021-2026) Table 193. Latin America Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 194. Latin America Intravenous Injection General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 195. Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 196. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 197. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2026) Table 198. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2027-2032) & (k units) Table 199. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Market Share Forecast by Country (2027-2032) Table 200. Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 201. Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 202. Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Share by Country (2021-2026) Table 203. Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 204. Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Share Forecast by Country (2027-2032) Table 205. Key Raw Materials Table 206. Raw Materials Key Suppliers Table 207. Intravenous Injection General Anesthesia Drugs Distributors List Table 208. Intravenous Injection General Anesthesia Drugs Customers List Table 209. Research Programs/Design for This Report Table 210. Authors List of This Report Table 211. Secondary Sources Table 212. Primary Sources List of Figures Figure 1. Intravenous Injection General Anesthesia Drugs Image Figure 2. Global Intravenous Injection General Anesthesia Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Injection General Anesthesia Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Injection General Anesthesia Drugs Sales (2021-2032) & (k units) Figure 5. Propofol Image Figure 6. Global Propofol Sales YoY Growth (2021-2032) & (k units) Figure 7. Sevoflurane Image Figure 8. Global Sevoflurane Sales YoY Growth (2021-2032) & (k units) Figure 9. Remifentanil Image Figure 10. Global Remifentanil Sales YoY Growth (2021-2032) & (k units) Figure 11. Etomidate Image Figure 12. Global Etomidate Sales YoY Growth (2021-2032) & (k units) Figure 13. Isoflurane Image Figure 14. Global Isoflurane Sales YoY Growth (2021-2032) & (k units) Figure 15. Other Image Figure 16. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 17. Global Intravenous Injection General Anesthesia Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Intravenous Injection General Anesthesia Drugs Market Share by Type 2025 VS 2032 Figure 19. North America Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 20. North America Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 21. Europe Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Europe Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 25. Latin America Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Intravenous Injection General Anesthesia Drugs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hopitals Image Figure 32. Global Hopitals Sales YoY Growth (2021-2032) & (k units) Figure 33. Clinics Image Figure 34. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Intravenous Injection General Anesthesia Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Intravenous Injection General Anesthesia Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 40. North America Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 41. Europe Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Europe Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 45. Latin America Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Market Share in Value by Application in 2025 Figure 49. North America Intravenous Injection General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Intravenous Injection General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Intravenous Injection General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Intravenous Injection General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Intravenous Injection General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Intravenous Injection General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Intravenous Injection General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Intravenous Injection General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Intravenous Injection General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Intravenous Injection General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Intravenous Injection General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Intravenous Injection General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Intravenous Injection General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Intravenous Injection General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Intravenous Injection General Anesthesia Drugs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Intravenous Injection General Anesthesia Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Propofol
  • Sevoflurane
  • Remifentanil
  • Etomidate
  • Isoflurane
  • Other
Applications
  • Hopitals
  • Clinics
  • Others
Companies covered
  • Aspen Pharma
  • Hikma Pharmaceuticals
  • Maruishi
  • Maruishi
  • Piramal
  • AstraZeneca
  • AbbVie
  • Baxter Healthcare
  • B.Braun
  • Fresenius-Kabi
  • China National Medicines Guorui Pharmaceutical Co.,Ltd.
  • Hengrui
  • Nhwa
  • Lunan Pharmaceutical Group Corporation
  • Xi'an Libang
  • Yichang Humanwell

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Injection General Anesthesia Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intravenous Injection General Anesthesia Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intravenous Injection General Anesthesia Drugs Market by Type
  6. 1.3.1 Propofol
  7. 1.3.2 Sevoflurane
  8. 1.3.3 Remifentanil
  9. 1.3.4 Etomidate
  10. 1.3.5 Isoflurane
  11. 1.3.6 Other
  12. 1.4 Global Intravenous Injection General Anesthesia Drugs Market Size by Type
  13. 1.4.1 Global Intravenous Injection General Anesthesia Drugs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Intravenous Injection General Anesthesia Drugs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Intravenous Injection General Anesthesia Drugs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Intravenous Injection General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Intravenous Injection General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Intravenous Injection General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intravenous Injection General Anesthesia Drugs Industry Trends
  2. 2.2 Intravenous Injection General Anesthesia Drugs Industry Drivers
  3. 2.3 Intravenous Injection General Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 Intravenous Injection General Anesthesia Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intravenous Injection General Anesthesia Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Intravenous Injection General Anesthesia Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Intravenous Injection General Anesthesia Drugs Price (2021-2026)
  4. 3.4 Global Intravenous Injection General Anesthesia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous Injection General Anesthesia Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Intravenous Injection General Anesthesia Drugs Company, Product Type & Application
  7. 3.7 Global Intravenous Injection General Anesthesia Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous Injection General Anesthesia Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous Injection General Anesthesia Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous Injection General Anesthesia Drugs Tier 1, Tier 2, and Tier 3
4 Intravenous Injection General Anesthesia Drugs Regional Status and Outlook
  1. 4.1 Global Intravenous Injection General Anesthesia Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intravenous Injection General Anesthesia Drugs Historic Market Size by Region
  3. 4.2.1 Global Intravenous Injection General Anesthesia Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intravenous Injection General Anesthesia Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intravenous Injection General Anesthesia Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intravenous Injection General Anesthesia Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Intravenous Injection General Anesthesia Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intravenous Injection General Anesthesia Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intravenous Injection General Anesthesia Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intravenous Injection General Anesthesia Drugs by Application
  1. 5.1 Intravenous Injection General Anesthesia Drugs Market by Application
  2. 5.1.1 Hopitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Intravenous Injection General Anesthesia Drugs Market Size by Application
  6. 5.2.1 Global Intravenous Injection General Anesthesia Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Intravenous Injection General Anesthesia Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Intravenous Injection General Anesthesia Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Intravenous Injection General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Intravenous Injection General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Intravenous Injection General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aspen Pharma
  2. 6.1.1 Aspen Pharma Company Information
  3. 6.1.2 Aspen Pharma Business Overview
  4. 6.1.3 Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Portfolio
  6. 6.1.5 Aspen Pharma Recent Developments
  7. 6.2 Hikma Pharmaceuticals
  8. 6.2.1 Hikma Pharmaceuticals Company Information
  9. 6.2.2 Hikma Pharmaceuticals Business Overview
  10. 6.2.3 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Portfolio
  12. 6.2.5 Hikma Pharmaceuticals Recent Developments
  13. 6.3 Maruishi
  14. 6.3.1 Maruishi Company Information
  15. 6.3.2 Maruishi Business Overview
  16. 6.3.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio
  18. 6.3.5 Maruishi Recent Developments
  19. 6.4 Maruishi
  20. 6.4.1 Maruishi Company Information
  21. 6.4.2 Maruishi Business Overview
  22. 6.4.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio
  24. 6.4.5 Maruishi Recent Developments
  25. 6.5 Piramal
  26. 6.5.1 Piramal Company Information
  27. 6.5.2 Piramal Business Overview
  28. 6.5.3 Piramal Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Piramal Intravenous Injection General Anesthesia Drugs Product Portfolio
  30. 6.5.5 Piramal Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Intravenous Injection General Anesthesia Drugs Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 AbbVie
  38. 6.7.1 AbbVie Company Information
  39. 6.7.2 AbbVie Business Overview
  40. 6.7.3 AbbVie Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AbbVie Intravenous Injection General Anesthesia Drugs Product Portfolio
  42. 6.7.5 AbbVie Recent Developments
  43. 6.8 Baxter Healthcare
  44. 6.8.1 Baxter Healthcare Company Information
  45. 6.8.2 Baxter Healthcare Business Overview
  46. 6.8.3 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Portfolio
  48. 6.8.5 Baxter Healthcare Recent Developments
  49. 6.9 B.Braun
  50. 6.9.1 B.Braun Company Information
  51. 6.9.2 B.Braun Business Overview
  52. 6.9.3 B.Braun Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 B.Braun Intravenous Injection General Anesthesia Drugs Product Portfolio
  54. 6.9.5 B.Braun Recent Developments
  55. 6.10 Fresenius-Kabi
  56. 6.10.1 Fresenius-Kabi Company Information
  57. 6.10.2 Fresenius-Kabi Business Overview
  58. 6.10.3 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Portfolio
  60. 6.10.5 Fresenius-Kabi Recent Developments
  61. 6.11 China National Medicines Guorui Pharmaceutical Co.,Ltd.
  62. 6.11.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
  63. 6.11.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview
  64. 6.11.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Portfolio
  66. 6.11.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
  67. 6.12 Hengrui
  68. 6.12.1 Hengrui Company Information
  69. 6.12.2 Hengrui Business Overview
  70. 6.12.3 Hengrui Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hengrui Intravenous Injection General Anesthesia Drugs Product Portfolio
  72. 6.12.5 Hengrui Recent Developments
  73. 6.13 Nhwa
  74. 6.13.1 Nhwa Company Information
  75. 6.13.2 Nhwa Business Overview
  76. 6.13.3 Nhwa Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Nhwa Intravenous Injection General Anesthesia Drugs Product Portfolio
  78. 6.13.5 Nhwa Recent Developments
  79. 6.14 Lunan Pharmaceutical Group Corporation
  80. 6.14.1 Lunan Pharmaceutical Group Corporation Company Information
  81. 6.14.2 Lunan Pharmaceutical Group Corporation Business Overview
  82. 6.14.3 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Portfolio
  84. 6.14.5 Lunan Pharmaceutical Group Corporation Recent Developments
  85. 6.15 Xi'an Libang
  86. 6.15.1 Xi'an Libang Company Information
  87. 6.15.2 Xi'an Libang Business Overview
  88. 6.15.3 Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Portfolio
  90. 6.15.5 Xi'an Libang Recent Developments
  91. 6.16 Yichang Humanwell
  92. 6.16.1 Yichang Humanwell Company Information
  93. 6.16.2 Yichang Humanwell Business Overview
  94. 6.16.3 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Portfolio
  96. 6.16.5 Yichang Humanwell Recent Developments
7 North America by Country
  1. 7.1 North America Intravenous Injection General Anesthesia Drugs Sales by Country
  2. 7.1.1 North America Intravenous Injection General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intravenous Injection General Anesthesia Drugs Market Size by Country
  6. 7.2.1 North America Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intravenous Injection General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intravenous Injection General Anesthesia Drugs Sales by Country
  2. 8.1.1 Europe Intravenous Injection General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intravenous Injection General Anesthesia Drugs Market Size by Country
  6. 8.2.1 Europe Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intravenous Injection General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intravenous Injection General Anesthesia Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intravenous Injection General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intravenous Injection General Anesthesia Drugs Sales by Country
  2. 10.1.1 South America Intravenous Injection General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intravenous Injection General Anesthesia Drugs Market Size by Country
  6. 10.2.1 South America Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intravenous Injection General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intravenous Injection General Anesthesia Drugs Value Chain Analysis
  2. 12.1.1 Intravenous Injection General Anesthesia Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intravenous Injection General Anesthesia Drugs Production Mode & Process
  7. 12.2 Intravenous Injection General Anesthesia Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intravenous Injection General Anesthesia Drugs Distributors
  10. 12.2.3 Intravenous Injection General Anesthesia Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst